Frequency of treated hypothyroidism and effect on disease complications in COVID-19 patients in Razi Hospital of Ahvaz
Immunopathologia Persa · 22.09.2025 · 12 (1) · e40562
DOI: 10.34172/ipp.2023.40562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunopathologia Persa, online erschienen am 22.09.2025. Verfasst von Mona Hoseini und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
COVID-19 infection (SARS-CoV-2) is associated with high morbidity and mortality rates, and worse outcomes have been reported for various morbidities. The impact of pre-existing hypothyroidism on COVID-19 outcomes is unclear.
Objectives
This study aimed to evaluate the frequency of treated hypothyroidism and its effect on disease complications in COVID-19 patients in Razi hospital of Ahvaz. Patients and Methods: This cross-sectional study was conducted on patients with a laboratory and computed tomography (CT) confirmed COVID-19 diagnosis between August 2021 and December 2021 in Razi hospital in Ahvaz. The medical records of all patients were reviewed, and patient’s characteristics and outcomes related to COVID-19, including severe disease, hospitalization in intensive care unit (ICU), need for mechanical or invasive ventilation, and all-cause mortality, was collected. The presence of hypothyroidism was identified based on the patient’s medical history in the medical record.
Results
Of 850 patients with COVID-19 positive, 59 patients (6.9%) had pre-existing hypothyroidism and received thyroid hormone replacement therapy. Hypothyroidism was not associated with increased risk of ICU admission (odds ratio [OR]: 0.447; 95% CI: 0.216-0.925, P=0.030), severe disease (OR: 1.237; 95% CI: 0.688-2.223, P=0.447) mechanical ventilation (OR: 1.785; 95% CI: 0.894-3.562; P=0.064) and death (OR: 0.997; 95% CI: 0.478-2.080; P=0.993).
Conclusion
Our study showed that underlying hypothyroidism does not lead to worse outcomes and complications in patients with COVID-19. It suggests that hypothyroidism is not associated with a worse prognosis and should not be considered among the comorbidities that indicate a risk factor for COVID-19 severity and its complication.
Zitieren
APA
Hoseini, M., Moradi, L., Shahbazian, H. B., Zaman, F., & Amiri, F. (2025). Frequency of treated hypothyroidism and effect on disease complications in COVID-19 patients in Razi Hospital of Ahvaz. Immunopathologia Persa, 12(1), e40562. https://doi.org/10.34172/ipp.2023.40562
Vancouver
Hoseini M, Moradi L, Shahbazian HB, Zaman F, Amiri F. Frequency of treated hypothyroidism and effect on disease complications in COVID-19 patients in Razi Hospital of Ahvaz. Immunopathologia Persa. 2025;12(1):e40562. doi:10.34172/ipp.2023.40562
BibTeX
@article{Hoseini2025,
author = {Hoseini, Mona and Moradi, Leila and Shahbazian, Hajieh Bibi and Zaman, Ferdos and Amiri, Fatemeh},
title = {Frequency of treated hypothyroidism and effect on disease complications in COVID-19 patients in Razi Hospital of Ahvaz},
journal = {Immunopathologia Persa},
year = {2025},
volume = {12},
number = {1},
pages = {e40562},
doi = {10.34172/ipp.2023.40562}
}
EUVIMED